HUBEI GUANGJI PHARMACEUTICAL CO., LTD.
- Country
- Ownership
- -
- Established
- 1993-05-28
- Employees
- 93
- Market Cap
- -
- Website
- https://www.guangjipharm.com
- Introduction
The company was founded in 1969 and listed on the Shenzhen Stock Exchange in 1999. It is a state-owned high-tech enterprise with 54 years of experience. It is the only provincial pharmaceutical listed company in Hubei Province. Changjiang Industrial Investment Group is the controlling shareholder of the company. The company mainly produces vitamin B2, B6, B12, sodium isobutyric acid, lactic acid and lactate series products, gluconic acid series products, starch series products, and pharmaceutical preparation products. It is a major global supplier of vitamin B2 products, a high-tech enterprise, an invisible champion in the pillar industry segment of Hubei Province, a small giant specializing in new giants, and the first batch of enterprises to go to the cloud. The company's industry is pharmaceutical manufacturing. It mainly produces vitamin B2, B6 and pharmaceutical products, and is mainly engaged in R&D, production and sales of vitamin raw products. The company's main products are divided into raw material series products and formulation series products. Among them: raw material series products are pharmaceutical grade, food grade, 98% feed grade, 80% feed grade riboflavin and riboflavin sodium phosphate; formulation series products are oral solid preparations and large infusions, isoVC sodium, lactic acid and lactate series products, gluconic acid series products, starch series products, etc. The company's trademark was rated as “Famous Trademark of Hubei Province” and recognized as “China's Famous Trademark” by the State Administration for Industry and Commerce, the feed additive VB2 (riboflavin) product was rated as “Hubei Famous Brand Product”, pharmaceutical-grade riboflavin was rated as “Excellent Enterprise Brand for Exporting Raw Materials in the Chinese Chemical Pharmaceutical Industry”, and the “Kanjiang” brand Vitamin B2 was recognized as a “Huanggang Time-honored Brand”. In 2018, the company received the 9th Pharmaceutical Observer's “2018 Most Commercial Innovative Pharmaceutical Enterprise” certificate, the 20th China International Hi-Tech Fair “Excellent Product Award” certificate, national green factory, national intellectual property advantage enterprise, and selected as a science reform enterprise by the State Council's State-owned Assets Administration Commission.
Clinical Trials
0
Trial Phases
0 Phases
Drug Approvals
42
Drug Approvals
Valacyclovir Hydrochloride Tablets
- Product Name
- 盐酸伐昔洛韦片
- Approval Number
- 国药准字H20247316
- Approval Date
- Dec 12, 2024
Adefovir Dipivoxil Tablets
- Product Name
- 阿德福韦酯片
- Approval Number
- 国药准字H20140111
- Approval Date
- Apr 22, 2024
Valacyclovir Hydrochloride Tablets
- Product Name
- 盐酸伐昔洛韦片
- Approval Number
- 国药准字H20093192
- Approval Date
- May 22, 2023
Pantoprazole Sodium Enteric-Coated Tablets
- Product Name
- 泮托拉唑钠肠溶片
- Approval Number
- 国药准字H20093467
- Approval Date
- May 22, 2023
Linezolid and Glucose Injection
- Product Name
- 利奈唑胺葡萄糖注射液
- Approval Number
- 国药准字H20233283
- Approval Date
- Mar 21, 2023
- Prev
- 1
- 2
- 3
- 4
- 5
- Next